InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 9.45
+0.08 (0.85%)
Apr 3, 2025, 4:08 PM HKT
InnoCare Pharma Revenue
In the year 2024, InnoCare Pharma had annual revenue of 1.01B CNY with 36.68% growth. InnoCare Pharma had revenue of 311.70M in the quarter ending December 31, 2024, with 54.94% growth.
Revenue
1.01B CNY
Revenue Growth
+36.68%
P/S Ratio
14.87
Revenue / Employee
926.95K CNY
Employees
1,089
Market Cap
19.38B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| WuXi Biologics | 19.87B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |